STRIDES PHARMA SCI LTD Intrinsic Value
STAR · Healthcare · Current price ₹1,074.9
Is STRIDES PHARMA SCI LTD undervalued?
DocStoX estimates the fair value of STRIDES PHARMA SCI LTD at ₹885 per share, versus the current market price of ₹1,075. That puts the stock about -17.6% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹471), Relative P/E (₹1,830), Graham floor (₹676). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹471 (bear) to ₹885 (base) to ₹1,830 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,075 versus an intrinsic value of ₹885, STRIDES PHARMA SCI LTD currently offers -17.6% of negative margin (i.e. a premium).
More on STRIDES PHARMA SCI LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.